Sutured versus Sutureless Dural Substitutes: Experience from a Government Tertiary Care Hospital in India

Abstract Dural substitutes have emerged as favorable alternatives to autologous grafts. This shift in approach is evident in the growing use of sutureless grafts (e.g., DuraGen) over traditional sutured options (e.g., bovine pericardial patch). This study was conducted to gain insights into the choice between the two in terms of the rate of postoperative complications. This prospective study was conducted between May 15, 2023 and January 31, 2024 at a tertiary-care government hospital in India. The patients received sutured (bovine pericardial patch) or sutureless (DuraGen patch) dural substitutes. Success in both groups was defined by the absence of postoperative complications. Wound healing was evaluated on postoperative day (POD) 3, 10, and 14. Follow-up assessments occurred at 1 and 3 months. Cerebrospinal fluid pooling was assessed by computed tomography (immediately after surgery and on POD 10) and brain magnetic resonance imaging (after 1 month). A total of 50 patients received sutured (bovine pericardial patch; n = 25) or sutureless (DuraGen patch; n = 25) dural substitutes to repair the dural defect that occurred after resection of cranial (62%) and spinal (20%) tumors. The bovine pericardial patch application was successful in 21 patients (84.0%), whereas the DuraGen patch application was successful in 23 patients (92.0%). The success rates with the bovine pericardial patch were 100% in patients with spinal tumors and patients who underwent foramen magnum decompression, 33.3% in patients with meningocele myelocystocele, and 81.8% in patients with cranial tumors. The success rates with the DuraGen patch were 80% in patients with spinal tumors and 95% in patients with cranial tumors. Sutureless grafts like DuraGen offer rapid application, reduced infection risk, and suitability for complex areas like the skull base. Sutured grafts may be preferred for larger defects due to their adaptability and inherent strength.

Authors

Institutions

Publication Details

Journal
Asian Journal of Neurosurgery
Published
2025-12-30
DOI
https://doi.org/10.1055/s-0045-1814389
Primary Topic
Head and Neck Surgical Oncology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sutured versus Sutureless Dural Substitutes: Experience from a Government Tertiary Care Hospital in India

Harish Naik, Skhandheshwaran Panchapakesan, Vernon Velho
Asian Journal of Neurosurgery
Head and Neck Surgical Oncology
article

Sutured versus Sutureless Dural Substitutes: Experience from a Government Tertiary Care Hospital in India

Harish Naik, Skhandheshwaran Panchapakesan, Vernon Velho
article en

Abstract

Abstract Dural substitutes have emerged as favorable alternatives to autologous grafts. This shift in approach is evident in the growing use of sutureless grafts (e.g., DuraGen) over traditional sutured options (e.g., bovine pericardial patch). This study was conducted to gain insights into the choice between the two in terms of the rate of postoperative complications. This prospective study was conducted between May 15, 2023 and January 31, 2024 at a tertiary-care government hospital in India. The patients received sutured (bovine pericardial patch) or sutureless (DuraGen patch) dural substitutes. Success in both groups was defined by the absence of postoperative complications. Wound healing was evaluated on postoperative day (POD) 3, 10, and 14. Follow-up assessments occurred at 1 and 3 months. Cerebrospinal fluid pooling was assessed by computed tomography (immediately after surgery and on POD 10) and brain magnetic resonance imaging (after 1 month). A total of 50 patients received sutured (bovine pericardial patch; n = 25) or sutureless (DuraGen patch; n = 25) dural substitutes to repair the dural defect that occurred after resection of cranial (62%) and spinal (20%) tumors. The bovine pericardial patch application was successful in 21 patients (84.0%), whereas the DuraGen patch application was successful in 23 patients (92.0%). The success rates with the bovine pericardial patch were 100% in patients with spinal tumors and patients who underwent foramen magnum decompression, 33.3% in patients with meningocele myelocystocele, and 81.8% in patients with cranial tumors. The success rates with the DuraGen patch were 80% in patients with spinal tumors and 95% in patients with cranial tumors. Sutureless grafts like DuraGen offer rapid application, reduced infection risk, and suitability for complex areas like the skull base. Sutured grafts may be preferred for larger defects due to their adaptability and inherent strength.

Asian Journal of Neurosurgery
Grant Medical College and Sir Jamshedjee Jeejeebhoy Group of Hospitals (IN)
Openalex Percentile: Top 25%
Head and Neck Surgical Oncology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.